Young people's health

摘要

Objective: This study used a high-resolution melting (HRM) technique to detect paternal mutations for the noninvasive prenatal diagnosis (NIPD) of β-thalassemia and sickle cell anemia (HbS). We also determined the levels of cell-free fetal DNA and total cell-free DNA. Methods: We used the HRM technique for fetal genotyping of paternal mutations in maternal plasma from 32 pregnancies at risk of β-thalassemia and 57 pregnancies at risk of HbS. The DNA levels in maternal plasma were measured using real-time quantitative PCR. Multiples of the median (MoM) values were calculated in women at risk for β-thalassemia or HbS. Results: Twenty-two paternal mutations were detected in 89 pregnant women. Although we were successfully able to detect the paternal β-thalassemia mutations, the mutant HbS fetuses could not be distinguished from maternal background in the early weeks of pregnancy. The detection of DYS14 in male fetuses was 100%. The MoM values of women at high risk of having HbS-affected fetuses were higher than those for the other groups. Conclusion: High-resolution melting is a useful method for NIPD of β-thalassemias by detecting paternal mutations in the maternal plasma. Cell-free fetal DNA quantification and MoM values were not informative for HbS or β-thalassemias in early pregnancy. What's already known about this topic? The noninvasive prenatal detection of paternal mutations in β-thalassemias is achievable using a high-resolution melting technique with cell-free fetal DNA. This is the first study from Turkey to test the diagnostic performance and practical applicability of this technique in a clinical setting. What does this study add? The high-resolution melting technique is useful for detection of paternal mutations of β-thalassemias and for detection during the early stage of pregnancy using cell-free fetal DNA. This analysis reduces the risk for a double heterozygous fetus without using an invasive method such as chorionic villus sampling.